Jason Ford

Executive Search 🔁 Management Consulting: Biotech, Pharma, MedTech. Nonprofit. Drug Development. Rare & Common. Oncology. Neurology. RNA. Gene Tx. AI. DeSci.

[Jason Ford @JasonFord6]

Global regulation is a strategic game of chess. With ICH E6(R3) evolving, 'Regulatory-First' thinking in ClinOps is vital. Harmonizing FDA, EMA, and APAC standards ensures trials move with precision.

#ClinOps #Biotech #RegulatoryAffairs

[Jon Rosser @RosserJobs]

I’ll be launching my own executive search firm soon.

In the meantime, my focus is on relationships outside of Indianapolis.

Over the years, I’ve helped clients hire CFOs, Controllers, FP&A, HR, Operations, and Supply Chain leaders.

Always open to connecting.

[PepGen @PepGenTx]

Today, PepGen’s President & CEO, James McArthur, PhD, will participate in “The Emerging Therapeutic Landscape in Myotonic Dystrophy Type 1” panel at the @Oppenheimer CNS and Neuro-Muscular Summit.
#DM1 #MyotonicDystrophy

[Jason Ford @JasonFord6]

ClinOps is the strategic heartbeat of biotech. Balancing speed, cost, and quality is the ultimate training ground for the C-suite.

We identify leaders who turn operational excellence into mission-driven results.

#ClinOps #BiotechLeadership #Strategy

[Jason Ford @JasonFord6]

Site selection is more than a map; it's a culture. Global ClinOps demands Cultural Intelligence: navigating local infrastructure with purpose. We find the leaders who turn global challenges into clinical success.

#ClinicalOperations #Biotech #GlobalHealth

[PepGen @PepGenTx]

Today, PepGen’s EVP, Head of Research & Development, Paul Streck, MD, MBA, will present our ongoing research in #MyotonicDystrophy type 1 (#DM1) in the Industry Workshop at the 2026 New Directions in Biology and Disease of Skeletal Muscle Conference.

[Jason Ford @JasonFord6]

ClinOps is the conductor of the global biotech orchestra: harmonizing time zones, AI, and regulations into one seamless study. We find the leaders who keep your mission on beat.

Together, we drive innovation.

#ClinOps #Biotech

[Jason Ford @JasonFord6]

@RosserJobs Sometimes the best candidates take a little longer to engage.

[Jason Ford @JasonFord6]

@RosserJobs Yeah. There are exceptions but give us the two weeks to make sure we have done a big push.

[PepGen @PepGenTx]

On Sunday, June 7, PepGen’s EVP, Head of Research & Development, Paul Streck, MD, MBA, will present in the Industry Workshop at the 2026 New Directions in Biology and Disease of Skeletal Muscle Conference. We look forward to hearing from leaders in the muscle biology field throughout the meeting.

Thank you, @UFMyology for organizing.
#MyotonicDystrophy #DM1

[Jason Ford @JasonFord6]

@BeamTx @AlphaFriend Behold the power of industry expertise and nonprofit passion.

[Jason Ford @JasonFord6]

@RosserJobs Contingent equals placing candidates, retained equals solving business problems

[Jason Ford @JasonFord6]

@RosserJobs There are no rules.

[Jason Ford @JasonFord6]

@RosserJobs I guess they do have one rule so maybe that wasn’t 100% true - no contingent work on this side
Love that business when worked with a big team. I think clients asked themselves if they’re willing to do a contingent. Why would I need to retain them?

[Jason Ford @JasonFord6]

@RosserJobs If you’re gonna be so generous with your fee percentages and guarantee percentage, you’re certainly well within your rights to ask for more upfront. Mitigate your risk a bit.
I love the flat fee approach !

[Jason Ford @JasonFord6]

The small biotech trade-off: One asset, ten hats. Being a 'generalist scientist' offers unmatched growth, but the narrow pipeline means the stakes couldn't be higher. It’s a fine line we walk.

#BiotechCareers #ExecutiveSearch #StartupLife

[Jason Ford @JasonFord6]

Milestone based career:  Navigating the 2026 biotech landscape requires a new mindset. Today’s leaders are prioritizing equity upside but with a disciplined eye on funding and clinical milestones. It’s the rise of the milestone-based career.

#Biotech #Leadership

[AscendisPharma @AscendisPharma]

Today is #WorldHypoparaDay! #AscendisPharma is raising awareness of this complex #raredisease, which can lead to significant multi-organ and quality-of-life impacts. #hypoparathyroidism